Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2018, Vol. 23 ›› Issue (4): 377-382.doi: 10.12092/j.issn.1009-2501.2018.04.003

Previous Articles     Next Articles

Protective effects of Baicalin to the human melanocyte cocultured with H2O2

ZHU Yiping, JIN Rong, LIN Fuquan, ZHOU Miaoni, WANG Suiquan, XU Aie   

  1. The Third People's Hospital in Hangzhou Affiliated to Zhejiang Chinese Medicine University, Hangzhou 310009, Zhejiang, China
  • Received:2017-12-27 Revised:2018-02-22 Online:2018-04-26 Published:2018-04-13

Abstract:

 AIM: To study the mechanism of anti-oxidant and melanocyte protection by Baicalin.  METHODS: Different concentration of Baicalin and H2O2 were cocultured with normal human melanocyte. Cell proliferation was detected by cell counting kit-8 assay, morphology of the human melanocyte was observed by ordinary inverted microscope, and LDH assay was used to detect cell viability. For mechanism research, DCFH-DA ROS level was assayed by flow cytometry. Induced HSP70 from melanocyte was detected using HSP70 high sensitivity ELISA kit. By RT-PCR, mRNA levels of CAT and GPX1 were dectected. RESULTS: Baicalin has obvious protective effects on melanocytes damage caused by H2O2. Compared with control group,in Baicalin groups, cell shape was changed and increased. In 12.5, 25, 50 μmol/L Baicalin groups, the effects of on melanocyte proliferation rate were higher than the control group (P<0.05). Baicalin inhibited the expression of LDH in black pigment cells in a dose-dependent manner, there was statistically significant difference (P<0.05). After H2O2 oxidative damage of melanocytes, Baicalin could significantly promote the expression of CAT and GPX1 mRNA, and the secretion of HSP70 was significantly increased. CONCLUSION: Baicalin protects human melanocytes from oxidative damage by inhibiting H2O2-induced apoptosis. It is referential for the treatment of vitiligo.

Key words: Baicalin, melanocyte, oxidative damage, vitiligo

CLC Number: